CD38-directed Cytolytic Antibody [EPC]
3 drugs in this class with 153,839 total adverse event reports.
3 Drugs
153,839 Total Reports
73,759 Serious Reports
23,183 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Bortezomib | BORTEZOMIB | 87,536 | 36,870 | 13,924 |
| 2 | Daratumumab | DARATUMUMAB | 38,558 | 23,738 | 4,930 |
| 3 | Carfilzomib | CARFILZOMIB | 27,745 | 13,151 | 4,329 |